Effect of a Potent Platelet-Activating Factor Antagonist, WEB-2086, on Asthma

A Multicenter, Double-Blind Placebo-Controlled Study in Japan
  • G. Tamura
  • T. Takishima
  • S. Mue
  • S. Makino
  • K. Itoh
  • T. Miyamoto
  • T. Shida
  • S. Nakajima
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 416)


Platelet-activating factor (PAF) has been suggested to be an important chemical mediator in bronchial asthma1). When given by inhalation, PAF produces short-term bronchoconstriction in both normal2) and asthmatic subjects2,3), increases airway reactivity in normal volunteers4,5), stimulates leukotriene and thromboxane A2 production in asthmatics6), and also worsens gas exchange in mild asthma7). In aminal models, it has been reported that exogenous PAF causes bronchoconstriction, microvascular leakage, mucous hypersecretion, an increase in bronchial responsiveness, and eosinophil recruitment into the airways of guinea pigs1). Thus, PAF induces various pathophysiologic changes relevant to bronchial asthma.


Platelet Activate Factor Allergy Clin Immunol Baseline Period Daily Variability Platelet Activate Factor Antagonist 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. J. Barnes, K. F. Chung, C. P. Page. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988; 81: 919–934.PubMedCrossRefGoogle Scholar
  2. 2.
    F. M. Cuss, C. M. S. Dixon, P. J. Barnes. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; 2: 189–92.PubMedCrossRefGoogle Scholar
  3. 3.
    R. Louis, T. Bury, J. L. Corhay, M. F. Radermecker. Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects. Chest 1994; 106: 1094–9.Google Scholar
  4. 4.
    B. B. Vargaftig, J. Lefort, M. Chignard, J. Benveniste. Platelet-activating factor induces a platelet dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 1080; 65: 185–92.CrossRefGoogle Scholar
  5. 5.
    M. G. Kaye, L. J. Smith. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 1990; 141: 993–7.PubMedCrossRefGoogle Scholar
  6. 6.
    I. K. Taylor, P. S. Ward, G. W. Taylor, C. T. Dollery, R. W. Fuller. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. J Appl Physiol 1991; 71: 1396–402.PubMedGoogle Scholar
  7. 7.
    M. A. Felez, J. Roca, J. A. Barbera, C. Santos, M. Rotger, K. F. Chung, R. Rodriguez-Roisin. Inhaled platelet-activating factor worsens gas exchange in mild asthma. Am J Respir Crit Care Med 1994; 150: 369–73.PubMedCrossRefGoogle Scholar
  8. 8.
    W. S. Adamus, H. Heuer, C. J. Meade, G. Frey, H. M. Brecht. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. Eur J Clin Pharmacol 1988; 35: 237–40.PubMedCrossRefGoogle Scholar
  9. 9.
    W. S. Adamus, H. Heuer, C. J. Meade, H. M. Brecht. Safety tolerability and pharmacologic activity of mulitiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects. Clin Pharmacol Ther 1989; 45: 270–6.PubMedCrossRefGoogle Scholar
  10. 10.
    V. A. Alabaster, R. F. Keir, M. J. Parry, R. N. de Souza. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. Agents Actions (Suppl.) 1991; 34: 221–7.Google Scholar
  11. 11.
    B. J. O’Connor, S. Uden, T. J. Carty, J. D. Eskra, P. J. Barnes, K. F. Chung. Inhibitory effect of UK-74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. Am J Respir Crit Care Med 1994; 150: 35–40.PubMedCrossRefGoogle Scholar
  12. 12.
    D. P. S. Spence, S. L. Johnston, R. M. A. Calverley, R Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning, J. Winter, S. T. Holgate. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149: 1142–8.PubMedCrossRefGoogle Scholar
  13. 13.
    W. S. Adamus, H. O. Heuer, C. J. Meade, J. C. Schilling. Inhibitory effects of the new PAF acether antagonist WEB 2086 on pharmacologic changes induced by PAF inhalation in human beings. Clin Pharmacol Ther 1990; 47: 456–62.PubMedCrossRefGoogle Scholar
  14. 14.
    A. Freitag, R. M. Watson, G. Matsos, C. Eastwood, P. M. O’Byrne. Effect of a platelet-activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 1993; 48: 594–8.PubMedCrossRefGoogle Scholar
  15. 15.
    L. M. Kuitert, K. P. Hui, S. Uthayarkumar, W. Burke, A. C. Newland, S. Uden, N. C. Barnes. Effect of platelet activating factor antagonist UK-74,505 on the early and late response to allergen. Am Rev Respir Dis 1993; 147: 82–6.PubMedCrossRefGoogle Scholar
  16. 16.
    R. G. Townley, R. Eda, R. J. Hopp, A. K. Bewtra, M. S. Gillen. The effect of RP 59227, a platelet activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics. J Lipid Mediat Cell Signal 1994; 10: 345–53.PubMedGoogle Scholar
  17. 17.
    M. Chan-Yeung, S. Lam, H. Chan, K. S. Tse, H. Salari. The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J Allergy Clin Immunol 1991; 87: 667–73.PubMedCrossRefGoogle Scholar
  18. 18.
    J. A. Burgers, P. L. Bruynzeel, H. J. Mengelers, J. Kreukniet, J. W. Akkerman. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction. J Lipid Mediat 1993; 7: 135–49.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • G. Tamura
    • 1
  • T. Takishima
    • 2
  • S. Mue
    • 3
  • S. Makino
    • 4
  • K. Itoh
    • 5
  • T. Miyamoto
    • 6
  • T. Shida
    • 6
  • S. Nakajima
    • 7
  1. 1.Tohoku UniversityJapan
  2. 2.Chest Institute of TechnologyJapan
  3. 3.Sendai UniversityJapan
  4. 4.Dokkyo UniversityJapan
  5. 5.University of TokyoJapan
  6. 6.Japan Asthma and Allergy ClinicJapan
  7. 7.Kinki UniversityJapan

Personalised recommendations